secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2026-06-17T18:19:23+00:00
Accession:  0001437749-26-020926
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell annual meeting results: directors elected, equity plan and officer exculpation approved
--------------------------------------------------------------------------------

- All seven director nominees elected with >99% of votes cast; broker non-votes 2,209,901.
- Non-binding advisory resolution on executive compensation approved with 92.4% of votes cast.
- 2025 Stock Option and Incentive Plan approved with 90.39% of votes cast.
- Charter amendment for officer exculpation approved with 53.62% of total outstanding shares.
- Ratification of Wipfli LLP as auditor for FY2026 with 99.28% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000143774926020926/0001437749-26-020926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000143774926020926/iccc20260615_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer